Optimizing Ribozymes for Somatic Cell Gene Therapy

Publisher： Karger

E-ISSN： 1660-2129|6|1|78-83

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.6, Iss.1, 1998-02, pp. : 78-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homologous Recombination Based Gene Therapy

By  

Nephron Experimental Nephrology, Vol. 7, Iss. 1, 1999-01 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Human Unrestricted Somatic Stem Cell Administration Fails to Protect Nude Mice from Cisplatin-Induced Acute Kidney Injury

By  

Nephron Experimental Nephrology, Vol. 123, Iss. 3-4, 2013-08 ,pp. : 11-21

Karger

Access to resources Recommend Favorite

Animal Models of Alport Syndrome: Advancing the Prospects for Effective Human Gene Therapy

By  

Nephron Experimental Nephrology, Vol. 8, Iss. 1, 2000-01 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Cell Therapy for Kidney Injury: Different Options and Mechanisms - Kidney Progenitor Cells

By  

Nephron Experimental Nephrology, Vol. 126, Iss. 2, 2014-05 ,pp. : 64-69

Karger

Access to resources Recommend Favorite

Cell-Specific Expression of the IP3 Receptor Gene Family in the Kidney

By  

Nephron Experimental Nephrology, Vol. 8, Iss. 4-5, 2000-07 ,pp. : 215-218

Karger

Access to resources Recommend Favorite